Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cannas

Showing results (751-760 of 788) with videos related to

Pageof 79
Sort By:
Neurobiology of Aging|July 26, 2015
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestryGiuseppe Borghero, Maura Pugliatti, Francesco Marrosu, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 19, 2015
Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY studyMaria Stella Baccillieri, Gianni Gasparini, Luca Benacchio, et al.
Molecular Cancer Therapeutics|December 5, 2023
ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid NeoplasmsAlberto J Arribas, Sara Napoli, Luciano Cascione, et al.
Cells|April 30, 2021
Effects of Genotypes and Treatment on Oxygenscan Parameters in Sickle Cell DiseaseCamille Boisson, Minke A E Rab, Elie Nader, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasmsAlberto J Arribas, Sara Napoli, Luciano Cascione, et al.
BMJ Open|November 29, 2024
Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study)Jerome Stirnemann, Jacques Serratrice, Tamara Mann, et al.
Journal of Neurology|August 16, 2015
C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian populationAntonino Cannas, Paolo Solla, Giuseppe Borghero, et al.
Neurobiology of Aging|August 16, 2014
Genetic architecture of ALS in SardiniaGiuseppe Borghero, Maura Pugliatti, Francesco Marrosu, et al.
Neurogenetics|April 3, 2013
The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonismsAntonino Cannas, Giuseppe Borghero, Gian Luca Floris, et al.
Journal of Virological Methods|November 25, 2017
Evaluation of a rapid and sensitive RT-qPCR assay for the detection of Ebola VirusM Biava, F Colavita, A Marzorati, et al.
Pageof 79

Showing results (751-760 of 788) with videos related to

Sort By:
Pageof 79
Neurobiology of Aging|July 26, 2015
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestryGiuseppe Borghero, Maura Pugliatti, Francesco Marrosu, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 19, 2015
Multicentre comparison Of shock efficacy using single-vs. Dual-coil lead systems and Anodal vs. cathodaL polarITY defibrillation in patients undergoing transvenous cardioverter-defibrillator implantation. The MODALITY studyMaria Stella Baccillieri, Gianni Gasparini, Luca Benacchio, et al.
Molecular Cancer Therapeutics|December 5, 2023
ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid NeoplasmsAlberto J Arribas, Sara Napoli, Luciano Cascione, et al.
Cells|April 30, 2021
Effects of Genotypes and Treatment on Oxygenscan Parameters in Sickle Cell DiseaseCamille Boisson, Minke A E Rab, Elie Nader, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasmsAlberto J Arribas, Sara Napoli, Luciano Cascione, et al.
BMJ Open|November 29, 2024
Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study)Jerome Stirnemann, Jacques Serratrice, Tamara Mann, et al.
Journal of Neurology|August 16, 2015
C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian populationAntonino Cannas, Paolo Solla, Giuseppe Borghero, et al.
Neurobiology of Aging|August 16, 2014
Genetic architecture of ALS in SardiniaGiuseppe Borghero, Maura Pugliatti, Francesco Marrosu, et al.
Neurogenetics|April 3, 2013
The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonismsAntonino Cannas, Giuseppe Borghero, Gian Luca Floris, et al.
Journal of Virological Methods|November 25, 2017
Evaluation of a rapid and sensitive RT-qPCR assay for the detection of Ebola VirusM Biava, F Colavita, A Marzorati, et al.
Pageof 79